ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 6 filers reported holding ONCOCYTE CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $0 | – | 10 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 10 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 10 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 10 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 10 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 10 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 10 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 10 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 10 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 10 | 0.0% | 0.00% | – |
Q1 2016 | $0 | – | 10 | 0.0% | 0.00% | – |
Q4 2015 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 719,282 | $2,359,245 | 0.35% |
Defender Capital, LLC. | 114,520 | $357,302 | 0.13% |